Nicklas Westerholm
Chief Executive Officer bei EGETIS THERAPEUTICS AB
Vermögen: 114 876 $ am 30.04.2024
Profil
Mr. Nicklas Westerholm is an Independent Director at Spago Nanomedical AB, a Chief Executive Officer at Egetis Therapeutics AB and a Chairman & Chief Executive Officer at Rare Thyroid Therapeutics International AB.
He is on the Board of Directors at Spago Nanomedical AB.
Mr. Westerholm was previously employed as a Vice President by AstraZeneca AB and an Investor Relations Contact by AstraZeneca PLC.
He received his undergraduate degree from the University of Stockholm and an undergraduate degree from Royal Institute of Technology.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
EGETIS THERAPEUTICS AB
0,07% | 31.12.2022 | 197 629 ( 0,07% ) | 114 876 $ | 30.04.2024 |
Aktive Positionen von Nicklas Westerholm
Unternehmen | Position | Beginn |
---|---|---|
EGETIS THERAPEUTICS AB | Chief Executive Officer | 16.06.2017 |
SPAGO NANOMEDICAL AB | Director/Board Member | 08.05.2019 |
Rare Thyroid Therapeutics International AB
Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Rare Thyroid Therapeutics International AB provides thyroid therapeutics research services. The company is headquartered in Stockholm, Sweden. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Nicklas Westerholm
Unternehmen | Position | Ende |
---|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | 01.06.2017 |
ASTRAZENECA PLC | Investor Relations Contact | 08.09.2011 |
Ausbildung von Nicklas Westerholm
University of Stockholm | Undergraduate Degree |
Royal Institute of Technology | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ASTRAZENECA PLC | Health Technology |
EGETIS THERAPEUTICS AB | Health Technology |
SPAGO NANOMEDICAL AB | Health Technology |
Private Unternehmen | 2 |
---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Rare Thyroid Therapeutics International AB
Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Rare Thyroid Therapeutics International AB provides thyroid therapeutics research services. The company is headquartered in Stockholm, Sweden. | Health Technology |